Projects per year
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 5 Finished
-
-
-
Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer
Weiner, G. J. (PI), Ballas, Z. K. (CoPI), Bishop, G. A. (CoPI), Cerhan, J. R. (CoPI), Dogan, A. M. (CoPI), Farooq, U. (CoPI), Feldman, A. L. (CoPI), Gupta, M. D. (CoPI), Habermann, T. M. (CoPI), Hohl, R. J. (CoPI), Houtman, J. C. D. (CoPI), Juweid, M. E. (CoPI), Kaufmann, S. H. (CoPI), Lentz, S. R. (CoPI), Link, B. K. (CoPI), Macon, W. R. (CoPI), Ratliff, T. L. (CoPI), Smith, B. J. (CoPI), Ansell, S. M. (CoPI), Syrbu, S. (CoPI), Geyer, S. (CoPI) & Witzig, T. E. (CoPI)
9/11/02 → 6/30/22
Project: Research project
-
C4 - Clinical Research
Ballas, Z. K. (PI), Link, B. B. K. (PI), Link, B. K. (PI) & Habermann, T. M. (PI)
10/1/01 → 6/30/12
Project: Research project
-
Eastern Cooperative Oncology Group
Habermann, T. M. (CoPI), Edmonson, J. H. (CoPI), Hahn, R. G. (CoPI) & Habermann, T. T. M. (PI)
6/1/85 → 2/28/14
Project: Research project
-
Anatomical Localization–Based Analysis of Relapsed Secondary Central Nervous System Aggressive B-Cell Lymphoma (R-SCNSL)
Okcu, I., Wang, Y., Li, Z., White, L. J., Johnston, P. B., Rosenthal, A. C., Paludo, J., King, R. L., Witzig, T. E., Habermann, T. M., Nowakowski, G. S. & Tun, H. W., Mar 2026, In: Hematological Oncology. 44, 2, e70182.Research output: Contribution to journal › Article › peer-review
Open Access -
Central nervous system involvement in patients with Richter transformation of chronic lymphocytic leukemia (CLL): the Mayo Clinic experience
Baccon, D., Atallah-Yunes, S. A., Hampel, P. J., Roeker, L. E., Kenderian, S. S., Muchtar, E., Kay, N. E., Koehler, A. B., Behnken, A. L., Wagner, C. C., Johnston, P. B., Nowakowski, G. S., Habermann, T. M., Hilal, T., Tsang, M., Leis, J. F., Rosenthal, A. C., Parrondo, R. D., Tun, H. W. & Shi, M. & 4 others, , Dec 2026, In: Blood cancer journal. 16, 1, 7.Research output: Contribution to journal › Letter › peer-review
Open Access -
Circulating levels of insulin-like growth factor I (IGF-I) and risk of multiple myeloma: An observational and Mendelian randomisation study
Benavente, Y., Hermosa, S., Papadimitriou, N., Clay-Gilmour, A., Brown, E. E., Hofmann, J. N., Rothman, N., Lan, Q., Berndt, S. I., Albanes, D., Purdue, M., Machiela, M. J., Chanock, S. J., Bhatti, P., Cozen, W., Norman, A., Slager, S. L., Cerhan, J. R., Rajkumar, V. & Kumar, S. K. & 37 others, , Jun 2026, In: British journal of haematology. 208, 6, p. 1942-1953 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Comparative Safety of Tocilizumab and Siltuximab in Castleman Disease: Pharmacovigilance Study
Nishimura, Y., Habermann, T. & Dispenzieri, A., Jan 2026, In: American journal of hematology. 101, 1, p. 165-168 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Comprehensive analysis of subtype-specific outcomes and management in Castleman disease: a 20-year cohort study
Nishimura, Y., Habermann, T., Gertz, M., Porrata, L., Johnston, P., Lin, Y., Buadi, F., Dingli, D., Wang, Y., Leung, N., Kourelis, T., Witzig, T., Warsame, R., Cook, J., Rosenthal, A. C., Sher, T., Tun, H. W. & Dispenzieri, A., Mar 10 2026, In: Blood Advances. 10, 5, p. 1487-1496 10 p.Research output: Contribution to journal › Article › peer-review
Open Access